Korro Bio (KRRO) Balance Sheet: Assets & Liabilities

Korro Bio (KRRO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Korro Bio reported total assets of $113.51M and total liabilities of $62.07M. Shareholders' equity was $51.44M, down 67.9% from $160.41M a year earlier. Total debt stood at $43.49M against $75.16M in cash and short-term investments, a net cash position of $31.67M. That puts debt-to-equity at 0.85, compared with 0.28 a year earlier.

Korro Bio Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Korro Bio, Inc. (KRRO) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	21.82	55.64	166.15	36.33	83.49	220.34	200.16	42.19	17.94
Short-Term Investments	53.33	70.45	0.00	18.92	35.04	0.00	17.20	0.00	0.00
Cash & Short-Term Investments	75.16	126.10	166.15	55.25	118.53	220.34	217.36	42.19	17.94
Accounts Receivable	0.97	1.70	0.00	0.00	0.14	0.34	0.81	0.16	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	6.25	3.74	6.58	1.84	1.24	4.38	3.20	0.59	0.02
Total Current Assets	82.37	131.53	172.73	57.08	119.78	225.06	221.36	42.94	17.96
Non-Current Assets
Property, Plant & Equipment (Net)	16.22	51.55	42.82	11.89	7.14	37.84	1.76	1.51	1.73
Long-Term Investments	10.03	36.96	3.41	4.54	11.72	1.82	0.00	0.00	0.00
Other Non-Current Assets	4.88	6.20	2.71	4.77	0.66	0.00	0.10	0.10	0.10
Total Non-Current Assets	31.13	94.71	48.94	16.66	7.80	39.66	1.86	1.61	1.83
Total Assets	113.51	226.24	221.66	73.74	127.58	264.72	223.22	44.55	19.79
Current Liabilities
Accounts Payable	1.65	3.99	7.28	2.61	0.79	5.51	1.22	1.86	0.99
Short-Term Debt	2.67	1.28	1.99	2.92	2.58	0.40	0.00	0.00	0.00
Current Portion of Long-Term Debt	-	-	-	-	0.83	-	-	-	-
Accrued Liabilities	3.50	6.17	1.47	3.18	0.44	-	-	-	-
Deferred Revenue	7.84	3.51	0.00	0.00	0.00	14.07	48.15	0.00	0.00
Other Current Liabilities	0.07	0.28	10.21	0.21	0.50	6.66	3.41	1.91	1.23
Total Current Liabilities	11.94	14.96	19.48	8.70	4.95	26.63	52.78	3.77	2.23
Non-Current Liabilities
Long-Term Debt	40.81	43.48	31.22	0.21	14.17	45.60	0.00	84.94	46.69
Other Non-Current Liabilities	1.48	7.38	1.05	0.00	0.00	0.00	0.18	0.35	0.51
Total Non-Current Liabilities	50.13	50.87	32.27	0.21	164.83	45.60	3.08	85.28	47.20
Total Liabilities	62.07	65.83	51.75	8.91	169.78	72.23	55.86	89.06	49.43
Stockholders' Equity
Common Stock	0.01	0.01	0.01	0.00	0.01	0.03	0.03	0.01	0.01
Retained Earnings	-383.85	-266.59	-183.01	-101.83	-43.80	-95.40	-68.89	-49.09	-29.92
Accumulated Other Comprehensive Income	0.21	0.27	-	0.00	-0.01	0.03	0.05	0.00	0.00
Additional Paid-in Capital	435.06	426.72	352.91	2.81	1.60	287.83	236.16	0.79	0.27
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.77	0.00
Shares Outstanding	9.42	9.38	8.02	8.00	8.00	-	-	-	-
Total Stockholders' Equity	51.44	160.42	169.91	64.83	-42.21	192.49	167.36	-48.28	-29.64
Total Liabilities & Equity	113.51	226.24	221.66	73.74	127.58	264.72	223.22	44.55	19.79

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Korro Bio Balance Sheet

How much debt does Korro Bio have?

Korro Bio had total debt of $43.49M as of Dec 31, 2025, against $75.16M in cash and short-term investments. Its debt-to-equity ratio was 0.85. Total debt was $44.77M a year earlier.

What are Korro Bio's total assets?

Korro Bio reported total assets of $113.51M as of Dec 31, 2025, down 49.8% from $226.24M a year earlier. Total liabilities were $62.07M.

What is Korro Bio's shareholders' equity?

Korro Bio's shareholders' equity was $51.44M as of Dec 31, 2025, or about $5.46 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition